Ibudilast is a pyrazolopyridine derivative used primarily as an anti-inflammatory agent in the treatment of conditions such as asthma, allergic rhinitis, and stroke-related inflammation. By inhibiting… Read more
Ibudilast is a pyrazolopyridine derivative used primarily as an anti-inflammatory agent in the treatment of conditions such as asthma, allergic rhinitis, and stroke-related inflammation. By inhibiting 5-lipoxygenase activity, this drug helps regulate the release of inflammatory mediators. This category provides access to high-quality reference standards essential for comprehensive pharmaceutical analysis. Laboratories rely on these Ibudilast-related compounds, including identified impurities and metabolites, to conduct rigorous impurity profiling and ensure regulatory compliance. Furthermore, the inclusion of stable isotope-labelled compounds, such as Ibudilast-d3 and Ibudilast-d7, offers critical internal standards for accurate quantification in mass spectrometry-based analytical testing. These reference materials are vital for method development, assay validation, and the ongoing quality control of pharmaceutical products to ensure consistency, safety, and efficacy throughout the development and manufacturing lifecycle.